桂枝茯苓汤联合甲硝唑治疗子宫内膜炎的炎症因子水平变化及妊娠率分析
医学与健康科学研究 · 2026
DOI: 10.65196/n5pg3c55 ↗Kurz gefasst
Fachartikel in der Zeitschrift 医学与健康科学研究, 2026. Verfasst von 晓燕 杨. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
This study aims to investigate the impact of Guizhi Fuling Decoction combined with metronidazole on the level of the inflammatory factor CD138 in the treatment of endometritis and its improvement effect on the pregnancy rate.
Methods
A total of 50 patients with endometritis treated from March 2020 to March 2022 were selected and divided into an experimental group (treated with Guizhi Fuling Decoction combined with metronidazole) and a control group (treated with metronidazole alone) according to the treatment plan. The changes in the inflammatory factor CD138 before and after treatment were detected, and the improvement in the pregnancy rate was analyzed.
Results
The level of the inflammatory factor CD138 in the combined treatment group significantly decreased, and the pregnancy rate was significantly higher than that in the control group.
Conclusion
The treatment of endometritis with Guizhi Fuling Decoction combined with metronidazole can effectively reduce the CD138 level and improve the pregnancy rate of patients, which is worthy of clinical promotion.
Zitieren
APA
杨, 晓. (2026). 桂枝茯苓汤联合甲硝唑治疗子宫内膜炎的炎症因子水平变化及妊娠率分析. 医学与健康科学研究. https://doi.org/10.65196/n5pg3c55
Vancouver
杨 晓. 桂枝茯苓汤联合甲硝唑治疗子宫内膜炎的炎症因子水平变化及妊娠率分析. 医学与健康科学研究. 2026. doi:10.65196/n5pg3c55
BibTeX
@article{2026,
author = {杨, 晓燕},
title = {桂枝茯苓汤联合甲硝唑治疗子宫内膜炎的炎症因子水平变化及妊娠率分析},
journal = {医学与健康科学研究},
year = {2026},
doi = {10.65196/n5pg3c55}
}
EUVIMED